1. Home
  2. Stocks
  3. Jbchepharm Share Price
  • Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • J B Chemicals & Pharmaceuticals Share Price

    Large Cap
    ₹1,875.6
    -25.35 (-1.33%)
    • Advice
    • Hold
    18 September, 2024 02:37 BSE: 506943 NSE: JBCHEPHARM ISIN: INE572A01036
    Split

    Start SIP in J B Chemicals & Pharmaceuticals

    Start SIP

    J B Chemicals & Pharmaceuticals Performance

    Day Range

    • Low 1,867
    • High 1,913
    ₹ 1,875

    52 Week Range

    • Low 1,244
    • High 2,030
    ₹ 1,875
    • Open Price1,913
    • Previous Close1,901
    • Volume56010

    J B Chemicals & Pharmaceuticals Chart

    • Over 1 Month -4.62%
    • Over 3 Month + 1.15%
    • Over 6 Month + 21%
    • Over 1 Year + 26.86%

    J B Chemicals & Pharmaceuticals Key Statistics

    P/E Ratio 49.6
    PEG Ratio 1.6
    Market Cap Cr
    Price to Book Ratio 10
    EPS 34.2
    Dividend 0.7
    Relative Strength Index 43.42
    Money Flow Index 44.66
    MACD Signal 5.79
    Average True Range 59.34

    J B Chemicals & Pharmaceuticals Investment Rating

    • Master Rating:

    • J B Chemicals & Phar Ltd has an operating revenue of Rs. 3,592.38 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 22% is great, ROE of 18% is exceptional. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 10% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -1% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 86 which is a GOOD score indicating consistency in earnings, a RS Rating of 44 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 46 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    J B Chemicals & Pharmaceuticals Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 952809800837853699
    Operating Expenses Qtr Cr 679614585602618538
    Operating Profit Qtr Cr 273195215235235161
    Depreciation Qtr Cr 404033323131
    Interest Qtr Cr 481291112
    Tax Qtr Cr 613748565433
    Net Profit Qtr Cr 17312612814514589
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 3,3332,893
    Operating Expenses Annual Cr 2,4192,219
    Operating Profit Annual in Cr 879665
    Depreciation Cr 135112
    Interest Annual Cr 4134
    Tax Annual Cr 195138
    Net Profit Annual Cr 543389
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 789629
    Cash from Investing Activity Annual Cr -412-956
    Cash from Financing Annual Activity Cr -374343
    Net Cash Flow Annual Cr 316
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 2,8862,442
    Fixed Assets Annual Cr 2,0011,877
    Total Non Current Assets Annual Cr 2,1982,072
    Total Current Assets Annual Cr 1,7151,398
    Total Assets Annual Cr 3,9143,470
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 186316
    ROE Annual % 1916
    ROCE Annual % 2519
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2823
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 1,004862845882896762
    Operating Expenses Qtr Cr 724664621638664599
    Operating Profit Qtr Cr 280198223244232164
    Depreciation Qtr Cr 414134323132
    Interest Qtr Cr 6912101214
    Tax Qtr Cr 633850585235
    Net Profit Qtr Cr 17712613415114288
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 3,5213,159
    Operating Expenses Annual Cr 2,5872,454
    Operating Profit Annual in Cr 897696
    Depreciation Cr 138114
    Interest Annual Cr 4436
    Tax Annual Cr 199145
    Net Profit Annual Cr 553410
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 801626
    Cash from Investing Activity Annual Cr -404-962
    Cash from Financing Annual Activity Cr -385357
    Net Cash Flow Annual Cr 1120
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 2,9232,480
    Fixed Assets Annual Cr 2,0231,899
    Total Non Current Assets Annual Cr 2,1412,026
    Total Current Assets Annual Cr 1,8531,528
    Total Assets Annual Cr 3,9943,554
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 188321
    ROE Annual % 1917
    ROCE Annual % 2520
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2722
    Invest in J B Chemicals & Pharmaceuticals

    J B Chemicals & Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹1,875.6
    -25.35 (-1.33%)
    pointer
    • Bullish Moving Average
    • ___
    • 5
    • Bearish Moving Average
    • ___
    • 11
    • 20 Day
    • ₹1,914.08
    • 50 Day
    • ₹1,891.34
    • 100 Day
    • ₹1,838.30
    • 200 Day
    • ₹1,726.73
    • 20 Day
    • ₹1,923.76
    • 50 Day
    • ₹1,889.62
    • 100 Day
    • ₹1,844.12
    • 200 Day
    • ₹1,735.98

    J B Chemicals & Pharmaceuticals Resistance and Support

    PIVOT
    ₹1,885.17
    Resistance
    First Resistance 1,903.73
    Second Resistance 1,931.87
    Third Resistance 1,950.43
    RSI 43.42
    MFI 44.66
    MACD Single Line 5.79
    MACD -3.22
    Support
    First Support 1,857.03
    Second Support 1,838.47
    Third Supoort 1,810.33

    J B Chemicals & Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 58,524 3,179,024 54.32
    Week 150,307 8,483,338 56.44
    1 Month 151,081 8,913,768 59
    6 Month 193,035 11,004,906 57.01

    J B Chemicals & Pharmaceuticals Result Highlights

    J B Chemicals & Pharmaceuticals Synopsis

    NSE-Medical-Diversified

    J B Chemicals & Phar is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 3298.64 Cr. and Equity Capital is Rs. 15.52 Cr. for the Year ended 31/03/2024. J B Chemicals & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 18/12/1976 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24390MH1976PLC019380 and registration number is 019380.
    Market Cap 29,524
    Sales 3,398
    Shares in Float 7.14
    No of funds 264
    Yield 0.64
    Book Value 10.22
    U/D Vol ratio 1.2
    LTDebt / Equity 1
    Alpha 0.05
    Beta 0.55

    J B Chemicals & Pharmaceuticals Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 53.77%53.78%53.83%53.86%
    Mutual Funds 15.04%15.45%15.66%15.57%
    Insurance Companies 1.93%2.36%2.3%2.45%
    Foreign Portfolio Investors 12.17%11.06%10.35%10.05%
    Financial Institutions/ Banks
    Individual Investors 14.38%14.69%15.16%15.33%
    Others 2.71%2.66%2.7%2.74%

    J B Chemicals & Pharmaceuticals Management

    Name Designation
    Mr. Arun Duggal Chairman & Ind.Director
    Mr. Nikhil Chopra WholeTime Director & CEO
    Mr. Prashant Kumar Non Executive Director
    Mr. Gaurav Trehan Non Executive Director
    Mr. Akshay Tanna Non Executive Director
    Mr. Sumit Bose Independent Director
    Ms. Padmini Khare Kaicker Independent Director

    J B Chemicals & Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    J B Chemicals & Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2024-08-08 Quarterly Results
    2024-05-17 Audited Results & Final Dividend
    2024-02-06 Quarterly Results & Interim Dividend
    2023-11-07 Quarterly Results
    2023-08-09 Quarterly Results
    Date Purpose Remarks
    2024-08-14 FINAL Rs.6.75 per share(675%)Final Dividend
    2024-02-16 INTERIM Rs.5.50 per share(550%)Interim Dividend
    2023-02-18 INTERIM Rs.8.50 per share(425%)Interim Dividend
    2022-02-24 INTERIM Rs.8.50 per share(425%)Interim Dividend
    2021-02-22 INTERIM Rs.8.50 per share(425%)Interim Dividend
    Date Purpose Remarks
    2023-09-18 Split Rs.0.00 split from Rs. 2/- to 1/-.

    J B Chemicals & Pharmaceuticals MF Shareholding

    Name Amount(cr)
    Nippon India Small Cap Fund - Growth 60,373
    Kotak Emerging Equity Scheme Growth 51,366
    Nippon India Multi Cap Fund - Growth 38,115
    Nippon India Growth Fund - Growth 33,707
    Axis Midcap Fund Growth 31,322

    J B Chemicals & Pharmaceuticals FAQs

    What is Share Price of J B Chemicals & Pharmaceuticals ?

    J B Chemicals & Pharmaceuticals share price is ₹1,875 As on 18 September, 2024 | 02:23

    What is the Market Cap of J B Chemicals & Pharmaceuticals ?

    The Market Cap of J B Chemicals & Pharmaceuticals is ₹29130.8 Cr As on 18 September, 2024 | 02:23

    What is the P/E ratio of J B Chemicals & Pharmaceuticals ?

    The P/E ratio of J B Chemicals & Pharmaceuticals is 49.6 As on 18 September, 2024 | 02:23

    What is the PB ratio of J B Chemicals & Pharmaceuticals ?

    The PB ratio of J B Chemicals & Pharmaceuticals is 10 As on 18 September, 2024 | 02:23

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     
    footer_form

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 29/07/2024 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.